Actinium Pharmaceuticals, Inc. (ATNM) Common Stock, Shares, Outstanding 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Actinium Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from 2010 to 2024.
  • Actinium Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending March 31, 2024 was 29.4M shares, a 14.3% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly Data (shares)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 29.4M +3.67M +14.3% Mar 31, 2024 10-Q 2024-04-26
Q4 2023 27.6M +1.96M +7.63% Dec 31, 2023 10-Q 2024-04-26
Q3 2023 27.4M +2.2M +8.73% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 27M +2.11M +8.5% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 25.7M +3.59M +16.2% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 25.7M +3.53M +15.9% Dec 31, 2022 10-K 2024-03-29
Q3 2022 25.2M +3.18M +14.4% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 24.9M +3.78M +17.9% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 22.1M +2.9M +15.1% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 22.1M +4.61M +26.3% Dec 31, 2021 10-K 2023-03-31
Q3 2021 22M +8.44M +62.2% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 21.1M +7.92M +60.1% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 19.2M -156M -89% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 17.5M +12M +219% Dec 31, 2020 10-K 2022-03-25
Q3 2020 13.6M -151M -91.8% Sep 30, 2020 10-Q 2020-10-23
Q2 2020 13.2M -149M -91.9% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 175M +55.7M +46.8% Mar 31, 2020 10-Q 2020-06-30
Q4 2019 5.49M -110M -95.3% Dec 31, 2019 10-K 2021-03-31
Q3 2019 165M +54.2M +49.1% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 162M +51.6M +46.7% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 119M +8.82M +8% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 116M +35.6M +44.5% Dec 31, 2018 10-K 2020-05-08
Q3 2018 110M +30.4M +38% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 110M +51.9M +88.8% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 110M +53.2M +93% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 80.1M +24.3M +43.5% Dec 31, 2017 10-K 2019-03-15
Q3 2017 80M +32.3M +67.6% Sep 30, 2017 10-Q 2017-11-03
Q2 2017 58.5M +11.2M +23.7% Jun 30, 2017 10-Q 2017-08-04
Q1 2017 57.2M +12.2M +27.2% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 55.8M +11.7M +26.6% Dec 31, 2016 10-K 2018-03-16
Q3 2016 47.7M +5.83M +13.9% Sep 30, 2016 10-Q 2016-10-28
Q2 2016 47.3M +6.81M +16.8% Jun 30, 2016 10-Q 2016-07-29
Q1 2016 44.9M +9.22M +25.8% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 44.1M +14.1M +47% Dec 31, 2015 10-K 2017-03-16
Q3 2015 41.9M +12.3M +41.5% Sep 30, 2015 10-Q 2015-10-30
Q2 2015 40.5M +12.9M +46.7% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 35.7M +10.1M +39.7% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 30M +5.41M +22% Dec 31, 2014 10-K 2016-03-11
Q3 2014 29.6M +5.96M +25.2% Sep 30, 2014 10-Q 2014-10-31
Q2 2014 27.6M +4.02M +17% Jun 30, 2014 10-Q 2014-08-12
Q1 2014 25.6M +4.17M +19.5% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 24.6M +3.17M +14.8% Dec 31, 2013 10-K 2015-03-16
Q3 2013 23.7M +12.5M +112% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 23.6M +12.4M +111% Jun 30, 2013 10-Q 2013-08-13
Q1 2013 21.4M +10.2M +91.8% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 21.4M +7.73M +56.5% Dec 31, 2012 10-K 2014-02-28
Q3 2012 11.2M 0 0% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 11.2M 0 0% Jun 30, 2012 10-Q/A 2012-08-29
Q1 2012 11.2M Mar 31, 2012 10-Q 2012-04-23
Q4 2011 13.7M +2.51M +22.5% Dec 31, 2011 10-K 2013-03-29
Q3 2011 11.2M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 11.2M Jun 30, 2011 10-Q 2011-08-12
Q4 2010 11.2M Dec 31, 2010 10-K 2012-04-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.